Register entry

Antares Pharma, Inc

Data as of · How to read this entry

Registered sites
1
Active NDC listings
11
Live patents
51
Countries
1
Base
United States
Authorisation

Registered operations

Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Antares Pharma, Inc.Registrant: Antares Pharma, Inc12500 Whitewater Dr, Hopkins, Minnesota (MN) 55343, United States (USA)Labelling, Finished drug manufacture, Packaging2182861133621198
Catalogue

Drug listings by form and route

11

11 active NDC listings: 11 human prescription drug. By marketing category: NDA 10, BLA 1.

Dosage formNDCs
injection, solution8
injection3
RouteNDCs
subcutaneous11
Labeller name on the listingNDCs
antares pharma, inc.11
Exclusivity

Patents and exclusivities

51
PatentProductCoversExpiry
8021335XYOSTED (AUTOINJECTOR)testosterone enanthateproductOct 2026
11497753XYOSTED (AUTOINJECTOR)testosterone enanthateproductMar 2030
10279131XYOSTED (AUTOINJECTOR)testosterone enanthateproductJul 2031
10357609XYOSTED (AUTOINJECTOR)testosterone enanthateproductAug 2031
10905827XYOSTED (AUTOINJECTOR)testosterone enanthateproductAug 2031
11446440XYOSTED (AUTOINJECTOR)testosterone enanthateproductAug 2031
10821072XYOSTED (AUTOINJECTOR)testosterone enanthateproductJun 2033
11844804XYOSTED (AUTOINJECTOR)testosterone enanthateuseJun 2033
10881798XYOSTED (AUTOINJECTOR)testosterone enanthateproductFeb 2034
11160751XYOSTED (AUTOINJECTOR)testosterone enanthateproductOct 2034
10238662XYOSTED (AUTOINJECTOR)testosterone enanthateproductFeb 2035
10912782XYOSTED (AUTOINJECTOR)testosterone enanthateproductFeb 2035
11813435XYOSTED (AUTOINJECTOR)testosterone enanthateproductFeb 2035
12629483XYOSTED (AUTOINJECTOR)testosterone enanthateproductAug 2035
11191908XYOSTED (AUTOINJECTOR)testosterone enanthateproductOct 2035
9744302XYOSTED (AUTOINJECTOR)testosterone enanthateproductNov 2035
9950125XYOSTED (AUTOINJECTOR)testosterone enanthateproductSept 2036
Catalogue

Marketed products

11
BrandGeneric nameForm / routeNDC
HYLENEX RecombinantHyaluronidaseinjection, solution, subcutaneous18657-117BLA
Otrexupmethotrexateinjection, solution, subcutaneous54436-010NDA
Otrexupmethotrexateinjection, solution, subcutaneous54436-012NDA
Otrexupmethotrexateinjection, solution, subcutaneous54436-015NDA
Otrexupmethotrexateinjection, solution, subcutaneous54436-017NDA
Otrexupmethotrexateinjection, solution, subcutaneous54436-020NDA
Otrexupmethotrexateinjection, solution, subcutaneous54436-022NDA
Otrexupmethotrexateinjection, solution, subcutaneous54436-025NDA
XYOSTEDtestosterone enanthateinjection, subcutaneous54436-200NDA
XYOSTEDtestosterone enanthateinjection, subcutaneous54436-250NDA
XYOSTEDtestosterone enanthateinjection, subcutaneous54436-275NDA
Compare

Comparable companies in United States

Enquiry

Common questions

Is Antares Pharma, Inc FDA approved?
Antares Pharma, Inc holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Antares Pharma, Inc's drugs manufactured?
The FDA register lists Hopkins, MN. Registered operations: labelling, finished drug manufacture, packaging.
What drugs does Antares Pharma, Inc make?
11 products are listed under Antares Pharma, Inc in the openFDA NDC Directory, most often as injection, solution; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.